ArriVent BioPharma (AVBP) PT Lowered to $29 at BTIG

October 7, 2026 5:03 AM EDT Send to a Friend
BTIG analyst Jeet Mukherjee lowered the price target on ArriVent BioPharma (NASDAQ: AVBP) to $29.00 (from $42.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login